CAMP4 Therapeutics Corporation (CAMP)
Last updated: 2026-10-20 18:28:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
CAMP4 Therapeutics Corporation (CAMP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.19, with a market capitalization of $198.93M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.88 to $7.75. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$198.93M | |
$3.18 | |
$801.55 | |
$0.39 | |
$3.14 | |
31.83K | |
264.47K | |
-- | |
$7.75 | |
$2.88 | |
-- | |
-- |
CAMP4 Therapeutics Corporation (CAMP) Stock Price Today
CAMP4 Therapeutics Corporation (CAMP) is currently trading at $3.19 as of 2026-10-20 18:27:00, up 1.59% ($0.05) from the previous close of $3.14
During today's regular trading session, CAMP has traded between $0.39 and $801.55, with a trading volume of 31.83K shares. The current price is near the lower end of today's range.
CAMP4 Therapeutics Corporation (CAMP) 7-Day Stock Price Change
Over the past seven days, CAMP4 Therapeutics Corporation (CAMP) moved from $3.77 to $3.19, representing a decline of 15.38% ($0.58).
The stock traded between $3.11 and $3.87 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 79.83 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
CAMP 52-Week Price Position
Position in Range: 6.4%
CAMP is currently trading at $3.19, placing it 6.4% of the way from its 52-week low of $2.88 to its 52-week high of $7.75. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is CAMP4 Therapeutics Corporation (CAMP)?
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases.
CAMP4 Therapeutics Corporation Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 48 |
| Exchange | NASDAQ |
| Company Website |
How to Buy CAMP4 Therapeutics Corporation (CAMP) Stock on MEXC
Eligible investors can buy real shares of CAMP4 Therapeutics Corporation (CAMP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is CAMP4 Therapeutics Corporation (CAMP) stock price today?
2.Is CAMP stock going up or down today?
3.What is CAMP pre-market price?
4.What is CAMP after-hours price?
5.Is CAMP stock trading now?
6.Where does CAMP sit relative to its 52-week high and low?
7.What sector is CAMP4 Therapeutics Corporation in?
8.What is CAMP4 Therapeutics Corporation's market capitalization and where is it listed?
9.How is CAMP valued in terms of P/E ratio and EPS?
10.Does CAMP4 Therapeutics Corporation pay a dividend?
Explore More US Stocks
Search Stocks
CAMP Stock Calculator
Estimate the value between CAMP shares and USD.
CAMP Shares to USD
1.00 CAMP shares = 3.19 USD
Calculations are estimates based on the latest available price and are for reference only.


